Ventas, Inc. (VTR) Analyst Ratings & Price Targets

Ventas, Inc.

VTR · NYSE

Analyst Consensus

Buy

21 analysts

$89

Current

—

Low

$102

Average

—

High

Average target implies +14.63% versus the current price.

Analyst Ratings Synthesis

Consensus is Buy from all 21 analysts, with a mean price target of $100. The supplied data provide no low or high targets, so target clustering and the width of the target spread cannot be measured. No named analyst is identified as most or least bullish, and no individual rating or target revisions are supplied for the week, preventing a directional revision assessment. The substantive evidence-based disagreement is operational rather than broker-specific: Ventas beat second-quarter FFO and revenue estimates, reported strong SHOP growth and raised its FY2026 earnings and investment outlook, yet the stock declined 7.43% over the week. The record does not identify why investors discounted the favorable update.

Rating Actions

No individual rating actions have been captured for VTRyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Research Reports

Links to freely available third-party research. Outlook labels are our classification of each article's stance, not a rating of our own.

Covering Firms

B OF A GLBL RES

BAIRD R W

BARCLAYS CAPITA

BMO CAPITAL MKT

CITIGROUP

CO FORECST

EDWARD JONES

EVERCORE ISI

EXANE BNP PARIB

JEFFERIES & CO.

JP MORGAN SECUR

KEYBANC CAP MKT

MIZUHO SECURITI

MORGAN STANLEY

RAYMOND JAMES

RBC CAPITAL

SCOTIABANK

STIFEL NICOLAUS

WEDBUSH SECURIT

WELLS FARGO SEC

ZACKS RESEARCH

Symbol: VTR
Type: Stock
Sector: Real Estate
Industry: Real Estate Investment Trusts
Exchange: NYSE

Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Key Issues

Bullish view

Strong SHOP growth, occupancy gains and rent growth lifted property-level results in the second quarter, supporting the case that senior housing demand can continue driving earnings.

Bearish view

The evidence confirms recent growth but does not establish how long occupancy and rent gains can persist, leaving durability of the SHOP acceleration unresolved.

Analyst Consensus

See all

Buy

21 analysts

$89

Current

—

Low

$102

Average

—

High

Average target implies +14.63% versus the current price.

Earnings History

BeatMissNo estimate

Ventas, Inc.

Analyst Consensus

Analyst Ratings Synthesis

Rating Actions

Research Reports

Covering Firms

Peers